Cardinal Health Inc (CAH) Shares Sold by Bellevue Group AG  Stephan Jacobs | Aug 17th, 2018
Bellevue Group AG lessened its stake in Cardinal Health Inc (NYSE:CAH) by 10.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,000 shares of the company's stock after selling 2,000 shares during the quarter. Bellevue Group AG's holdings in Cardinal Health were worth $879,000 at the end of the most recent reporting period.
Several other institutional investors also recently added to or reduced their stakes in the company. Global X Management Co. LLC increased its stake in Cardinal Health by 8.4% in the 1st quarter. Global X Management Co. LLC now owns 11,087 shares of the company's stock worth $695,000 after acquiring an additional 857 shares during the last quarter. Fort Washington Investment Advisors Inc. OH increased its stake in Cardinal Health by 58.0% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 9,530 shares of the company's stock worth $597,000 after acquiring an additional 3,499 shares during the last quarter. FDx Advisors Inc. increased its stake in Cardinal Health by 52.6% in the 1st quarter. FDx Advisors Inc. now owns 43,964 shares of the company's stock worth $2,756,000 after acquiring an additional 15,156 shares during the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH increased its stake in Cardinal Health by 470.5% in the 1st quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 86,459 shares of the company's stock worth $5,386,000 after acquiring an additional 71,304 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC bought a new stake in Cardinal Health in the 1st quarter worth approximately $241,000. Institutional investors own 89.98% of the company's stock. Get Cardinal Health alerts:
A number of research firms have issued reports on CAH. Mizuho reaffirmed a "hold" rating and issued a $53.00 price objective on shares of Cardinal Health in a research note on Sunday, August 12th. Robert W. Baird reduced their price objective on Cardinal Health from $51.00 to $50.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 7th. Royal Bank of Canada reaffirmed a "hold" rating and issued a $56.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 7th. Argus reduced their price objective on Cardinal Health from $85.00 to $75.00 and set a "buy" rating on the stock in a research note on Monday, July 16th. Finally, Zacks Investment Research raised Cardinal Health from a "strong sell" rating to a "hold" rating in a research note on Tuesday, July 3rd. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of "Hold" and an average target price of $62.00.
NYSE CAH opened at $50.45 on Friday. The company has a market cap of $15.04 billion, a PE ratio of 10.09, a P/E/G ratio of 1.78 and a beta of 0.99. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.53 and a current ratio of 1.07. Cardinal Health Inc has a fifty-two week low of $48.14 and a fifty-two week high of $75.75.
Cardinal Health (NYSE:CAH) last released its earnings results on Monday, August 6th. The company reported $1.01 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.93 by $0.08. The firm had revenue of $35.35 billion for the quarter, compared to the consensus estimate of $34.38 billion. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. The company's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 EPS. equities analysts expect that Cardinal Health Inc will post 5.04 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Stockholders of record on Monday, October 1st will be given a dividend of $0.4763 per share. The ex-dividend date is Friday, September 28th. This represents a $1.91 annualized dividend and a dividend yield of 3.78%. This is an increase from Cardinal Health's previous quarterly dividend of $0.48. Cardinal Health's payout ratio is currently 38.20%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.
Featured Story: Find a Trading Strategy That Works
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH). Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter . Ã‚